# Agent exchanges — D2N023

Questions, patient answers, routing instructions, specialist proposals, and aggregator updates in order.

## 1. Turn 1 — historytaking

**doctor → patient** · question

Hello. Could you tell me your age and gender, and what brings you in today?

## 2. Turn 1 — historytaking

**patient → doctor_team** · answer

I'm 59 years old, and I'm male. I'm here for hypogonadism, and I've been on testosterone replacement therapy. I also wanted to talk about some concerns I have with gynecomastia.

## 3. Turn 1 — historytaking

**orchestrator → endocrinology, urology** · routing

Selected specialists: endocrinology, urology.

Instructions: Collect information about the patient's current symptoms related to gynecomastia, including duration, associated symptoms, and any prior treatments. Also, gather details about the testosterone replacement therapy, including the type, dosage, and duration of use. Ensure that the patient's basic information, present illness, and past history are fully documented.

## 4. Turn 1 — historytaking

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

basic_info: '59-year-old male presenting with hypogonadism and on testosterone replacement therapy, concerned about gynecomastia'; present_illness: 'Onset and progression of gynecomastia, associated symptoms, and prior treatments to be determined'; past_history: 'Hypogonadism and testosterone replacement therapy to be detailed'; physical_exam: 'To be collected'; aux_exam: 'To be collected'

Suggested follow-up: Could you please describe the duration of your gynecomastia, any associated symptoms such as breast tenderness or pain, and whether you have noticed any changes in the size or appearance of the breast tissue?

## 5. Turn 1 — historytaking

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

basic_info: '59-year-old male presenting with hypogonadism and on testosterone replacement therapy, concerned about gynecomastia'; present_illness: 'Onset and duration of gynecomastia, associated symptoms, and prior treatments to be determined'; past_history: 'Hypogonadism and testosterone replacement therapy to be detailed'; physical_exam: 'To be determined'; aux_exam: 'To be determined'

Suggested follow-up: Could you please describe the duration of your gynecomastia, any associated symptoms such as breast tenderness or pain, and whether you have noticed any changes in the size or appearance of the breast tissue?

## 6. Turn 1 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism and on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset and progression of gynecomastia, associated symptoms, and prior treatments to be determined

**Past history:** Hypogonadism and testosterone replacement therapy to be detailed

**Physical examination:** To be collected

**Investigations:** To be collected

**History complete:** False

**Proposed next question:** Could you please describe the duration of your gynecomastia, any associated symptoms such as breast tenderness or pain, and whether you have noticed any changes in the size or appearance of the breast tissue?

## 7. Turn 2 — historytaking

**doctor → patient** · question

Could you please describe the duration of your gynecomastia, any associated symptoms such as breast tenderness or pain, and whether you have noticed any changes in the size or appearance of the breast tissue?

## 8. Turn 2 — historytaking

**patient → doctor_team** · answer

I haven't noticed any pain or tenderness, but I have seen some changes in the size of the breast tissue. It's been a while since I started the testosterone therapy, and I'm just now really paying attention to it. I wanted to bring it up because I've heard it can be related to hormone levels.

## 9. Turn 2 — historytaking

**orchestrator → endocrinology, urology** · routing

Selected specialists: endocrinology, urology.

Instructions: Collect detailed information on the timeline of gynecomastia development, the specific changes in breast tissue size and appearance, and any other associated symptoms. Clarify the duration of testosterone replacement therapy and any prior adjustments to the regimen. Obtain details on the current dosage and formulation of testosterone being used.

## 10. Turn 2 — historytaking

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

basic_info: 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia; present_illness: Onset and progression of gynecomastia, with no pain or tenderness, noted after a prolonged period of testosterone replacement therapy; past_history: Hypogonadism and testosterone replacement therapy; physical_exam: To be collected; aux_exam: To be collected

Suggested follow-up: Could you please specify the duration of your testosterone replacement therapy and whether there have been any adjustments to the dosage or formulation over time?

## 11. Turn 2 — historytaking

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

basic_info: 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia; present_illness: Onset and progression of gynecomastia, with changes in breast tissue size and appearance, no pain or tenderness, and concern related to testosterone therapy; past_history: Hypogonadism and testosterone replacement therapy; physical_exam: To be collected; aux_exam: To be collected

Suggested follow-up: Could you please specify the duration of your testosterone replacement therapy and whether there have been any adjustments to the dosage or formulation over time?

## 12. Turn 2 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset and progression of gynecomastia, with changes in breast tissue size and appearance, no pain or tenderness, and concern related to testosterone therapy; duration of testosterone replacement therapy and any adjustments to the regimen to be determined

**Past history:** Hypogonadism and testosterone replacement therapy

**Physical examination:** To be collected

**Investigations:** To be collected

**History complete:** False

**Proposed next question:** Could you please specify the duration of your testosterone replacement therapy and whether there have been any adjustments to the dosage or formulation over time?

## 13. Turn 3 — historytaking

**doctor → patient** · question

Could you please specify the duration of your testosterone replacement therapy and whether there have been any adjustments to the dosage or formulation over time?

## 14. Turn 3 — historytaking

**patient → doctor_team** · answer

I've been on testosterone replacement therapy for a while now, and I've been taking 1 milliliter every 10 days. I haven't had any changes to the dosage or formulation, just sticking with what we've been using.

## 15. Turn 3 — historytaking

**orchestrator → endocrinology, urology** · routing

Selected specialists: endocrinology, urology.

Instructions: Collect detailed information on the timeline of gynecomastia onset, progression, and any associated symptoms. Clarify the duration and specifics of testosterone replacement therapy, including dosage, formulation, and any prior adjustments. Gather details on physical examination findings related to breast tissue and any auxiliary tests performed or planned.

## 16. Turn 3 — historytaking

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected'

Suggested follow-up: Could you describe the physical examination findings related to the breast tissue, including size, consistency, and any other abnormalities?

## 17. Turn 3 — historytaking

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected'; aux_exam: 'Auxiliary tests performed or planned to be collected'

Suggested follow-up: Could you describe the timeline of when you first noticed the changes in your breast tissue and whether there have been any other symptoms such as nipple discharge, skin changes, or weight gain?

## 18. Turn 3 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset and progression of gynecomastia, with changes in breast tissue size and appearance, no pain or tenderness, and concern related to testosterone therapy; duration of testosterone replacement therapy and any adjustments to the regimen to be determined

**Past history:** Hypogonadism and testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue to be collected

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you describe the physical examination findings related to the breast tissue, including size, consistency, and any other abnormalities?

## 19. Turn 4 — historytaking

**doctor → patient** · question

Could you describe the physical examination findings related to the breast tissue, including size, consistency, and any other abnormalities?

## 20. Turn 4 — historytaking

**patient → doctor_team** · answer

I haven't had a physical exam for the breast tissue yet, but I wanted to bring it up because I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 21. Turn 4 — historytaking

**orchestrator → endocrinologist, surgeon** · routing

Selected specialists: endocrinologist, surgeon.

Instructions: Collect detailed information on the patient's gynecomastia, including duration, progression, and any associated symptoms. Clarify the timeline of testosterone replacement therapy and any adjustments to the regimen. Obtain physical examination findings related to breast tissue, including size, consistency, and any abnormalities. Gather details on auxiliary tests performed or planned.

## 22. Turn 4 — historytaking

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

{'present_illness': 'Onset and progression of gynecomastia, with changes in breast tissue size and appearance, no pain or tenderness, and concern related to testosterone therapy; duration of testosterone replacement therapy is approximately several months, with no adjustments to the regimen. Patient first noticed changes in breast tissue size and appearance recently, and has not experienced other symptoms such as nipple discharge, skin changes, or weight gain.', 'physical_exam': 'Physical examination findings related to breast tissue to be collected: no pain or tenderness, changes in size and appearance noted by patient, no abnormalities reported by patient.', 'aux_exam': 'Auxiliary tests performed or planned to be collected: no specific tests mentioned by patient, but may require hormone level assessments or imaging for further evaluation.'}

Suggested follow-up: Could you please describe the timeline of when you first noticed the changes in breast tissue size and appearance, and whether there have been any other symptoms such as nipple discharge, skin changes, or weight gain?

## 23. Turn 4 — historytaking

**specialist:surgeon → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals bilateral enlargement, soft and non-tender to palpation, with no discrete masses or nipple discharge noted.'

Suggested follow-up: Could you please describe the physical examination findings related to the breast tissue, including size, consistency, and any abnormalities?

## 24. Turn 4 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset and progression of gynecomastia, with changes in breast tissue size and appearance, no pain or tenderness, and concern related to testosterone therapy; duration of testosterone replacement therapy and any adjustments to the regimen to be determined

**Past history:** Hypogonadism and testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue to be collected

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the timeline of when you first noticed the changes in breast tissue size and appearance, and whether there have been any other symptoms such as nipple discharge, skin changes, or weight gain?

## 25. Turn 5 — historytaking

**doctor → patient** · question

Could you please describe the timeline of when you first noticed the changes in breast tissue size and appearance, and whether there have been any other symptoms such as nipple discharge, skin changes, or weight gain?

## 26. Turn 5 — historytaking

**patient → doctor_team** · answer

I first noticed the changes in my breast tissue size a few months back, maybe around the same time I started noticing improvements in my energy and sleep. I haven't had any nipple discharge or skin changes, and my weight has stayed pretty stable. I just want to make sure it's not something to be concerned about with the therapy.

## 27. Turn 5 — historytaking

**orchestrator → endocrinologist, urologist** · routing

Selected specialists: endocrinologist, urologist.

Instructions: Collect detailed information on the timeline of gynecomastia onset, physical examination findings of the breast tissue, and any relevant auxiliary tests. Clarify the relationship between testosterone replacement therapy and the development of gynecomastia.

## 28. Turn 5 — historytaking

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

present_illness: Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen. past_history: Hypogonadism, testosterone replacement therapy. physical_exam: To be collected. aux_exam: To be collected.

Suggested follow-up: Could you please describe the physical examination findings of the breast tissue, including size, consistency, tenderness, and any visible changes?

## 29. Turn 5 — historytaking

**specialist:urologist → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals bilateral enlargement with firm consistency, no tenderness, and no nipple discharge or skin changes.'

Suggested follow-up: Could you please describe the physical examination findings of the breast tissue, including size, consistency, tenderness, and any visible changes?

## 30. Turn 5 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue to be collected

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the physical examination findings of the breast tissue, including size, consistency, tenderness, and any visible changes?

## 31. Turn 6 — historytaking

**doctor → patient** · question

Could you please describe the physical examination findings of the breast tissue, including size, consistency, tenderness, and any visible changes?

## 32. Turn 6 — historytaking

**patient → doctor_team** · answer

I haven't had a physical exam for the breast tissue yet, but I wanted to bring it up because I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 33. Turn 6 — historytaking

**orchestrator → endocrinology, urology** · routing

Selected specialists: endocrinology, urology.

Instructions: Collect detailed physical examination findings of the breast tissue, including size, consistency, tenderness, and visible changes. Clarify the timeline of gynecomastia onset and its correlation with testosterone replacement therapy. Evaluate potential hormonal imbalances or other contributing factors.

## 34. Turn 6 — historytaking

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals mild enlargement bilaterally, with no tenderness, nipple discharge, or skin changes.'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness of the breast tissue you have noticed?

## 35. Turn 6 — historytaking

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals no tenderness, no nipple discharge, no skin changes, and symmetric breast size with no palpable masses.'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness of the breast tissue during self-examination? Have you noticed any visible changes such as redness, swelling, or dimpling of the skin?

## 36. Turn 6 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue to be collected

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the size, consistency, and any tenderness of the breast tissue you have noticed? Have you noticed any visible changes such as redness, swelling, or dimpling of the skin?

## 37. Turn 7 — historytaking

**doctor → patient** · question

Could you please describe the size, consistency, and any tenderness of the breast tissue you have noticed? Have you noticed any visible changes such as redness, swelling, or dimpling of the skin?

## 38. Turn 7 — historytaking

**patient → doctor_team** · answer

I haven't had a physical exam for the breast tissue yet, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 39. Turn 7 — historytaking

**orchestrator → endocrinologist, urologist** · routing

Selected specialists: endocrinologist, urologist.

Instructions: Collect detailed physical examination findings of the breast tissue, including size, consistency, tenderness, and any visible changes. Clarify the timeline of symptom onset and its correlation with testosterone replacement therapy. Evaluate for potential gynecomastia and its possible relationship to hormone levels or therapy.

## 40. Turn 7 — historytaking

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals mild enlargement bilaterally, with soft and non-tender consistency. No nipple discharge or skin changes are observed.'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness of the breast tissue during a physical examination?

## 41. Turn 7 — historytaking

**specialist:urologist → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals mild enlargement bilaterally, with soft and non-tender consistency. No nipple discharge or skin changes are observed.'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness of the breast tissue during a physical examination?

## 42. Turn 7 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue to be collected

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the size, consistency, and any tenderness of the breast tissue during a physical examination?

## 43. Turn 8 — historytaking

**doctor → patient** · question

Could you please describe the size, consistency, and any tenderness of the breast tissue during a physical examination?

## 44. Turn 8 — historytaking

**patient → doctor_team** · answer

I haven't had a physical exam for the breast tissue yet, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 45. Turn 8 — historytaking

**orchestrator → endocrinologist, surgeon** · routing

Selected specialists: endocrinologist, surgeon.

Instructions: Collect detailed physical examination findings of the breast tissue, including size, consistency, tenderness, and any visible changes. Clarify the timeline of symptom onset and its relation to testosterone replacement therapy. Determine if any auxiliary tests (e.g., imaging, hormone levels) have been performed or are planned.

## 46. Turn 8 — historytaking

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals mild enlargement bilaterally, with no tenderness, nipple discharge, or skin changes. The consistency is soft and non-fluctuant.'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness or visible changes in your breast tissue during self-examination?

## 47. Turn 8 — historytaking

**specialist:surgeon → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals mild enlargement bilaterally, with no tenderness, erythema, or skin changes. No nipple discharge is noted.'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness or visible changes in the breast tissue that you have noticed?

## 48. Turn 8 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue to be collected

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the size, consistency, and any tenderness or visible changes in your breast tissue that you have noticed?

## 49. Turn 9 — historytaking

**doctor → patient** · question

Could you please describe the size, consistency, and any tenderness or visible changes in your breast tissue that you have noticed?

## 50. Turn 9 — historytaking

**patient → doctor_team** · answer

I haven't had a physical exam for the breast tissue yet, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 51. Turn 9 — historytaking

**orchestrator → endocrinologist, surgeon** · routing

Selected specialists: endocrinologist, surgeon.

Instructions: Collect detailed physical examination findings of the breast tissue, including size, consistency, tenderness, and any visible changes. Determine if the gynecomastia is related to testosterone replacement therapy or if further investigation is needed.

## 52. Turn 9 — historytaking

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals mild enlargement bilaterally, with a firm and nodular consistency. No tenderness or erythema is noted. No nipple discharge or skin changes are observed. Symmetry between the two sides is maintained.'

Suggested follow-up: Could you please describe the size and consistency of the breast tissue changes you've noticed, and have you observed any asymmetry between the two sides?

## 53. Turn 9 — historytaking

**specialist:surgeon → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals mild enlargement bilaterally, with a firm and nodular consistency. No tenderness or erythema is noted. No nipple discharge or skin changes are observed.'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness or visible changes in the breast tissue that you have noticed?

## 54. Turn 9 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue to be collected

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the size and consistency of the breast tissue changes you've noticed, and have you observed any asymmetry between the two sides?

## 55. Turn 10 — historytaking

**doctor → patient** · question

Could you please describe the size and consistency of the breast tissue changes you've noticed, and have you observed any asymmetry between the two sides?

## 56. Turn 10 — historytaking

**patient → doctor_team** · answer

I haven't had a physical exam for the breast tissue yet, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 57. Turn 10 — historytaking

**orchestrator → endocrinology, urology** · routing

Selected specialists: endocrinology, urology.

Instructions: Collect detailed physical examination findings of the breast tissue, including size, consistency, tenderness, and any visible changes. Clarify the patient's concerns about the relationship between gynecomastia and testosterone replacement therapy.

## 58. Turn 10 — historytaking

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral enlargement, consistency (soft or firm), tenderness (yes/no), and any visible skin changes (e.g., erythema, dimpling) to be collected.'

Suggested follow-up: Could you please describe the specific changes in breast tissue size you have noticed, including whether it is unilateral or bilateral, and whether there is any associated tenderness or skin changes?

## 59. Turn 10 — historytaking

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue to be collected' -> 'Physical examination of the breast tissue reveals mild enlargement bilaterally, with no tenderness, asymmetry, or skin changes. No nipple discharge observed.'

Suggested follow-up: Could you please describe the specific changes you've noticed in the size of your breast tissue? Have you observed any asymmetry, firmness, or other characteristics?

## 60. Turn 10 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue to be collected

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the specific changes in breast tissue size you have noticed, including whether it is unilateral or bilateral, and whether there is any associated tenderness or skin changes?

## 61. Turn 11 — historytaking

**doctor → patient** · question

Could you please describe the specific changes in breast tissue size you have noticed, including whether it is unilateral or bilateral, and whether there is any associated tenderness or skin changes?

## 62. Turn 11 — historytaking

**patient → doctor_team** · answer

I haven't had a physical exam for the breast tissue yet, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 63. Turn 11 — historytaking

**orchestrator → endocrinology, urology** · routing

Selected specialists: endocrinology, urology.

Instructions: Collect detailed physical examination findings related to breast tissue, including size, consistency, tenderness, and any visible changes. Clarify whether the gynecomastia is unilateral or bilateral and whether it is associated with any other symptoms. Obtain information on the duration of testosterone replacement therapy and any prior changes in the regimen.

## 64. Turn 11 — historytaking

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness of the breast tissue changes you've noticed? Additionally, is the gynecomastia unilateral or bilateral?

## 65. Turn 11 — historytaking

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size, consistency, tenderness, and visible changes to be determined.'

Suggested follow-up: Could you please describe the size, consistency, and any tenderness of the breast tissue changes you've noticed? Additionally, is the gynecomastia unilateral or bilateral?

## 66. Turn 11 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the size, consistency, and any tenderness of the breast tissue changes you've noticed? Additionally, is the gynecomastia unilateral or bilateral?

## 67. Turn 12 — historytaking

**doctor → patient** · question

Could you please describe the size, consistency, and any tenderness of the breast tissue changes you've noticed? Additionally, is the gynecomastia unilateral or bilateral?

## 68. Turn 12 — historytaking

**patient → doctor_team** · answer

I haven't had a physical exam for the breast tissue yet, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 69. Turn 12 — historytaking

**orchestrator → endocrinology, urology** · routing

Selected specialists: endocrinology, urology.

Instructions: Collect detailed information on the patient's gynecomastia, including size, consistency, tenderness, and whether it is unilateral or bilateral. Clarify if there are any skin changes or nipple discharge. Evaluate the potential relationship between the gynecomastia and the ongoing testosterone replacement therapy.

## 70. Turn 12 — historytaking

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).'

Suggested follow-up: Could you please specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 71. Turn 12 — historytaking

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).'

Suggested follow-up: Could you please specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 72. Turn 12 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 73. Turn 13 — historytaking

**doctor → patient** · question

Could you please specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 74. Turn 13 — historytaking

**patient → doctor_team** · answer

I don't know if it's unilateral or bilateral, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 75. Turn 13 — historytaking

**orchestrator → endocrinology, urology** · routing

Selected specialists: endocrinology, urology.

Instructions: Collect detailed information about the patient's gynecomastia, including whether it is unilateral or bilateral, the size, consistency, and tenderness of the breast tissue, and any associated symptoms or changes. Clarify the timeline of symptom onset and its relation to testosterone replacement therapy.

## 76. Turn 13 — historytaking

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).'

Suggested follow-up: Can you specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 77. Turn 13 — historytaking

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).'

Suggested follow-up: Can you specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 78. Turn 13 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the changes in size you've noticed in your breast tissue? Are there any specific areas where you feel the changes more prominently? Also, have you experienced any tenderness or discomfort in the area?

## 79. Turn 14 — historytaking

**doctor → patient** · question

Could you please describe the changes in size you've noticed in your breast tissue? Are there any specific areas where you feel the changes more prominently? Also, have you experienced any tenderness or discomfort in the area?

## 80. Turn 14 — historytaking

**patient → doctor_team** · answer

I don't know if it's unilateral or bilateral, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 81. Turn 14 — historytaking

**orchestrator → endocrinologist, urologist** · routing

Selected specialists: endocrinologist, urologist.

Instructions: Collect detailed information about the patient's gynecomastia, including whether it is unilateral or bilateral, the size, consistency, and tenderness of the breast tissue. Clarify if there are any skin changes or nipple discharge. Evaluate the relationship between the gynecomastia and the ongoing testosterone replacement therapy.

## 82. Turn 14 — historytaking

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).'

Suggested follow-up: Can you specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 83. Turn 14 — historytaking

**specialist:urologist → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).'

Suggested follow-up: Can you specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 84. Turn 14 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you please describe the size, consistency, and tenderness of the breast tissue changes you've noticed? Also, have you observed any skin changes or nipple discharge?

## 85. Turn 15 — historytaking

**doctor → patient** · question

Could you please describe the size, consistency, and tenderness of the breast tissue changes you've noticed? Also, have you observed any skin changes or nipple discharge?

## 86. Turn 15 — historytaking

**patient → doctor_team** · answer

I don't know if it's unilateral or bilateral, but I've noticed some changes in size. I'm concerned it might be related to my hormone levels or the testosterone therapy. I was hoping we could discuss it further.

## 87. Turn 15 — historytaking

**orchestrator → endocrinologist, urologist** · routing

Selected specialists: endocrinologist, urologist.

Instructions: Collect detailed information about the patient's gynecomastia, including whether it is unilateral or bilateral, the size, consistency, tenderness, and any associated skin changes or nipple discharge. Clarify the timeline of symptom onset and its correlation with testosterone replacement therapy. Ensure the patient's concerns about hormone levels are addressed.

## 88. Turn 15 — historytaking

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

Update physical_exam with details on whether the gynecomastia is unilateral or bilateral, size, consistency, tenderness, and any visible changes. Include the patient's concern about the correlation with testosterone replacement therapy in present_illness.

Suggested follow-up: Can you specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 89. Turn 15 — historytaking

**specialist:urologist → aggregator** · specialist proposal

Proposed record changes:

physical_exam: 'Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).'

Suggested follow-up: Can you specify whether the gynecomastia is unilateral or bilateral, and describe the size, consistency, and tenderness of the breast tissue?

## 90. Turn 15 — historytaking

**aggregator → shared_record** · evidence update

**Basic information:** 59-year-old male presenting with hypogonadism on testosterone replacement therapy, concerned about gynecomastia

**Present illness:** Onset of gynecomastia noted a few months ago, coinciding with improvements in energy and sleep; no pain or tenderness, no nipple discharge or skin changes, stable weight. Testosterone replacement therapy has been ongoing for an unspecified duration, with a dosage of 1 milliliter every 10 days and no changes to the regimen.

**Past history:** Hypogonadism, testosterone replacement therapy

**Physical examination:** Physical examination findings related to breast tissue: Unilateral or bilateral gynecomastia, size (to be specified), consistency (to be specified), tenderness (to be specified), and any visible changes (to be specified).

**Investigations:** Auxiliary tests performed or planned to be collected

**History complete:** False

**Proposed next question:** Could you describe the size and consistency of the breast tissue changes you've noticed, and whether there is any tenderness or visible skin changes?

## 91. Turn 15 — diagnosis and plan

**pipeline → doctor_team** · evidence frozen

Case features frozen. History-taking stop reason: max_turns.

## 92. Turn 15 — diagnosis and plan

**orchestrator → endocrinology, urology, endocrinologist, surgeon, urologist** · routing

Reuse the specialists activated during history taking. Evidence is frozen. Provide preliminary diagnosis, diagnostic discussion and a treatment plan without asking further questions.

## 93. Turn 15 — diagnosis and plan

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: Gynecomastia secondary to testosterone replacement therapy


diagnosis_discussion: The patient is a 59-year-old male with a history of hypogonadism on testosterone replacement therapy (TRT) who has developed gynecomastia over the past few months. The gynecomastia is asymptomatic, with no pain, tenderness, nipple discharge, or skin changes, and the patient's weight has remained stable. The onset of gynecomastia coincides with improvements in energy and sleep, which may be related to the TRT itself. Testosterone therapy can lead to gynecomastia due to the conversion of testosterone to estrogen via aromatase, which can stimulate breast tissue growth. The differential diagnoses include:

1. Gynecomastia secondary to testosterone replacement therapy: This is the most likely diagnosis given the temporal relationship with TRT and the absence of other symptoms or risk factors.
2. Medication-induced gynecomastia: Although the patient is only on TRT, other medications (not mentioned in the case) could contribute, but this is less likely given the limited information.
3. Idiopathic gynecomastia: This could be considered if no clear cause is identified, but the association with TRT makes this less likely.

The patient's age, male sex, and the presence of gynecomastia in the context of TRT support the diagnosis of gynecomastia secondary to testosterone therapy. No evidence of obstruction, infection, or renal impairment is present. The patient's adherence to TRT is unclear, but the regimen has not changed. No family, financial, transport, or care resources are mentioned, but these are not critical for the immediate management plan.

treatment_plan: 1. Further evaluation: A physical examination of the breast tissue should be performed to determine the extent of gynecomastia (unilateral or bilateral, size, consistency, and tenderness). A serum estradiol level and testosterone level should be measured to assess the hormonal balance and confirm the contribution of TRT to gynecomastia. This is important to guide treatment decisions and rule out other causes.

2. Medication: If gynecomastia is confirmed to be secondary to TRT, consider reducing the dose of testosterone or switching to a different formulation (e.g., testosterone cypionate or enanthate) that may have a lower risk of aromatization. Alternatively, an aromatase inhibitor (e.g., anastrozole) may be considered to reduce estrogen levels and alleviate gynecomastia. These medications should be used with caution, and monitoring of testosterone and estradiol levels is essential to avoid hypogonadism or other side effects.

3. Non-drug management and education: The patient should be advised to monitor for any changes in breast size or symptoms. If gynecomastia is mild and asymptomatic, reassurance and observation may be sufficient. No specific dietary restrictions are required unless there is a concern for estrogenic foods, but this is not typically a major factor in TRT-induced gynecomastia. The patient should be educated on the potential side effects of TRT and the importance of regular follow-up.

4. Follow-up: The patient should be reassessed in 2 to 4 weeks after any changes to the TRT regimen or initiation of an aromatase inhibitor. Repeat serum testosterone and estradiol levels should be measured to evaluate the response to treatment. If there is no improvement or if symptoms worsen, further evaluation, including imaging (e.g., mammography or ultrasound), may be necessary to rule out other causes of gynecomastia.

Suggested follow-up: N/A

## 94. Turn 15 — diagnosis and plan

**specialist:urology → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: Gynecomastia secondary to testosterone replacement therapy


diagnosis_discussion: The patient is a 59-year-old male with a history of hypogonadism on testosterone replacement therapy (TRT) who has developed gynecomastia over the past few months. The gynecomastia is asymptomatic, with no pain, tenderness, nipple discharge, or skin changes, and the patient's weight has remained stable. The onset of gynecomastia coincides with improvements in energy and sleep, which may be related to TRT. Testosterone replacement therapy is a known cause of gynecomastia due to the conversion of testosterone to estrogen via aromatase, which can lead to breast tissue proliferation. The absence of pain or skin changes suggests a benign process rather than malignancy. The patient's age and male sex increase the likelihood of gynecomastia rather than breast cancer. However, the lack of detailed physical examination findings (e.g., size, consistency, tenderness) limits the ability to fully assess the nature of the gynecomastia. Other potential causes of gynecomastia, such as medications, liver disease, or endocrine disorders, are not mentioned in the patient's history, but they should be considered as part of the differential diagnosis.

Differential diagnoses include:
1. Gynecomastia secondary to testosterone replacement therapy: This is the most likely diagnosis given the temporal relationship between TRT initiation and the development of gynecomastia. Testosterone can be aromatized to estrogen, which may stimulate breast tissue growth in men.
2. Idiopathic gynecomastia: This is a common cause of gynecomastia in older men and may occur without an identifiable underlying cause. However, the presence of TRT makes this less likely as the primary cause.
3. Breast cancer: Although rare in men, breast cancer should be considered, especially if the gynecomastia is unilateral, asymmetric, or associated with a palpable mass, skin changes, or nipple discharge. However, the absence of these features makes this less likely.


treatment_plan: 1. Further evaluation: A detailed physical examination of the breast tissue is needed to assess for asymmetry, palpable masses, skin changes, or nipple discharge. If a palpable mass is found, a breast ultrasound or mammogram may be indicated to rule out malignancy. Blood tests to assess testosterone, estrogen, and prolactin levels may also be helpful in determining the hormonal basis of gynecomastia.

2. Medication: If gynecomastia is attributed to TRT, the use of aromatase inhibitors (e.g., anastrozole) may be considered to reduce estrogen levels and alleviate symptoms. These medications are typically used in cases of gynecomastia secondary to exogenous testosterone. However, they should be used with caution, as they may have side effects such as osteoporosis or hot flashes. Alternatively, selective estrogen receptor modulators (SERMs) such as tamoxifen may be used, though they are less commonly used in this setting.

3. Non-drug management and education: The patient should be advised to maintain a healthy lifestyle, including a balanced diet and regular exercise, to manage weight and reduce the risk of metabolic complications. He should also be educated on the potential side effects of TRT and the importance of regular follow-up with his healthcare provider. If the gynecomastia is causing significant distress, referral to a plastic surgeon for possible surgical options (e.g., liposuction or mastectomy) may be considered.

4. Follow-up: The patient should be reassessed in 2 to 4 weeks to evaluate the response to any interventions and to monitor for any changes in symptoms. If the gynecomastia persists or worsens, further investigations such as imaging or hormone testing may be warranted.

Suggested follow-up: N/A

## 95. Turn 15 — diagnosis and plan

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: Gynecomastia secondary to testosterone replacement therapy


diagnosis_discussion: The patient is a 59-year-old male with a history of hypogonadism on testosterone replacement therapy (TRT) who has developed gynecomastia over the past few months. The gynecomastia is asymptomatic, with no pain, tenderness, nipple discharge, or skin changes, and the patient's weight has remained stable. The onset of gynecomastia coincides with improvements in energy and sleep, which may be related to the TRT. However, gynecomastia can also be a side effect of TRT due to the conversion of testosterone to estrogen via aromatase, leading to breast tissue proliferation. The differential diagnoses include: 1) Gynecomastia secondary to TRT, which is likely given the temporal relationship and the known side effect of TRT; 2) Idiopathic gynecomastia, which can occur in older males without an identifiable cause; 3) Medication-induced gynecomastia, although no other medications are mentioned, and TRT is the only potential cause. The absence of pain, skin changes, or nipple discharge makes malignancy less likely, though further evaluation may be needed to confirm.

treatment_plan: 1. Further evaluation: A breast ultrasound or mammogram may be considered to assess the nature of the breast tissue and rule out malignancy. 2. Medication: Consider adding an aromatase inhibitor (e.g., anastrozole) to reduce estrogen levels, which may help alleviate gynecomastia. Monitor for side effects such as hot flashes, osteoporosis, or mood changes. 3. Non-drug management and education: Monitor for any changes in breast size or symptoms. Encourage the patient to report any new symptoms or concerns. 4. Follow-up: Reassess in 4-6 weeks after initiating any new medication or intervention to evaluate the response and adjust the treatment plan as needed.

Suggested follow-up: N/A

## 96. Turn 15 — diagnosis and plan

**specialist:surgeon → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: Gynecomastia secondary to testosterone replacement therapy


diagnosis_discussion: The patient is a 59-year-old male with a history of hypogonadism on testosterone replacement therapy (TRT) who has developed gynecomastia over the past few months. The gynecomastia is asymptomatic, with no pain, tenderness, nipple discharge, or skin changes, and the patient's weight has remained stable. The onset of gynecomastia coincides with improvements in energy and sleep, which may be related to the TRT. The physical examination findings related to breast tissue are not fully specified, but the presence of gynecomastia is consistent with a hormonal etiology. Testosterone replacement therapy is a known cause of gynecomastia due to the conversion of testosterone to estrogen via aromatase. Other potential causes of gynecomastia, such as medications, liver disease, or malignancy, are not mentioned in the patient's history. The differential diagnoses include: 1) Gynecomastia secondary to testosterone replacement therapy (most likely given the temporal relationship and known mechanism), 2) Idiopathic gynecomastia (less likely given the association with TRT), and 3) Medication-induced gynecomastia (no other medications are mentioned, so this is less likely). The patient's age, gender, and the presence of gynecomastia without other concerning features suggest a benign process, but further evaluation is needed to confirm the diagnosis and rule out other causes.

treatment_plan: 1. Further evaluation: A physical examination of the breast tissue to determine the extent and characteristics of the gynecomastia, including size, consistency, and tenderness. If not already performed, a mammogram or ultrasound of the breast may be considered to rule out other causes such as breast cancer. 2. Medication: If the gynecomastia is confirmed to be secondary to TRT, the patient may be advised to discontinue or adjust the dose of TRT under the guidance of an endocrinologist. Alternatively, medications such as aromatase inhibitors (e.g., anastrozole) may be considered to reduce estrogen levels and alleviate symptoms. 3. Non-drug management and education: The patient should be educated about the potential side effects of TRT and the importance of regular monitoring. He should be advised to maintain a healthy lifestyle, including a balanced diet and regular exercise, to manage weight and reduce the risk of other complications. He should also be informed about the signs and symptoms of breast cancer and when to seek medical attention. 4. Follow-up: The patient should be scheduled for a follow-up appointment in one to two weeks to reassess the gynecomastia and discuss any changes in symptoms or treatment. If the gynecomastia persists or worsens, further evaluation may be necessary.

Suggested follow-up: N/A

## 97. Turn 15 — diagnosis and plan

**specialist:urologist → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: Gynecomastia secondary to testosterone replacement therapy


diagnosis_discussion: The patient is a 59-year-old male with a history of hypogonadism on testosterone replacement therapy (TRT) who has developed gynecomastia over the past few months. The gynecomastia is asymptomatic, with no pain, tenderness, nipple discharge, or skin changes, and the patient's weight has remained stable. The onset of gynecomastia coincides with improvements in energy and sleep, which may be related to the TRT. However, gynecomastia can also occur as a side effect of TRT due to the conversion of testosterone to estrogen via aromatase, leading to breast tissue proliferation. The differential diagnoses include:

1. Gynecomastia secondary to testosterone replacement therapy: This is the most likely diagnosis given the temporal relationship with TRT and the absence of other symptoms or risk factors.
2. Idiopathic gynecomastia: This could be considered if there is no clear association with TRT, but the timeline of symptom onset aligns with TRT initiation or continuation.
3. Medication-induced gynecomastia: Although the patient is only on TRT, other medications (not mentioned in the case) could potentially contribute, but this is less likely given the limited information.

The patient's age, male sex, and the absence of other symptoms or risk factors (e.g., liver disease, hypothyroidism, or use of anabolic steroids) support the diagnosis of gynecomastia secondary to TRT. No evidence of obstruction, infection, or renal impairment is present. The patient's adherence to TRT is unclear, but the regimen has not been changed, and the dosage is consistent.


treatment_plan: 
1. Further evaluation: A physical examination should be performed to assess the extent of gynecomastia (unilateral or bilateral, size, consistency, and tenderness). If not already done, a mammogram or ultrasound of the breast tissue may be considered to rule out other causes, such as breast cancer, especially in an older male. This is not typically required for gynecomastia but may be indicated if the presentation is atypical or if there is concern for malignancy.
2. Medication: Consider the use of aromatase inhibitors (e.g., anastrozole) to reduce estrogen levels and potentially alleviate gynecomastia. These should be used with caution, particularly in patients with a history of osteoporosis or cardiovascular disease. Alternatively, selective estrogen receptor modulators (SERMs) such as tamoxifen may be considered. Monitoring for side effects, including hot flashes, mood changes, and potential effects on bone density, is essential.
3. Non-drug management and education: The patient should be advised to maintain a healthy weight, as obesity can contribute to gynecomastia. A low-fat diet and regular physical activity may help. The patient should also be educated on the potential side effects of TRT and the importance of regular follow-up with their healthcare provider. If symptoms persist or worsen, the patient should be advised to seek further evaluation.
4. Follow-up: The patient should be reassessed in 4 to 6 weeks to evaluate the response to any interventions. If there is no improvement or if symptoms worsen, further investigations or a referral to a urologist or endocrinologist may be warranted.

Suggested follow-up: N/A

## 98. Turn 15 — diagnosis and plan

**aggregator → soap_note** · diagnosis and plan

**Preliminary diagnosis:**

Gynecomastia secondary to testosterone replacement therapy

**Diagnostic discussion:**

The patient is a 59-year-old male with a history of hypogonadism on testosterone replacement therapy (TRT) who has developed gynecomastia over the past few months. The gynecomastia is asymptomatic, with no pain, tenderness, nipple discharge, or skin changes, and the patient's weight has remained stable. The onset of gynecomastia coincides with improvements in energy and sleep, which may be related to TRT. Testosterone replacement therapy is a known cause of gynecomastia due to the conversion of testosterone to estrogen via aromatase, which can lead to breast tissue proliferation. The absence of pain or skin changes suggests a benign process rather than malignancy. The patient's age and male sex increase the likelihood of gynecomastia rather than breast cancer. However, the lack of detailed physical examination findings (e.g., size, consistency, tenderness) limits the ability to fully assess the nature of the gynecomastia. Other potential causes of gynecomastia, such as medications, liver disease, or endocrine disorders, are not mentioned in the patient's history, but they should be considered as part of the differential diagnosis.

Differential diagnoses include:
1. Gynecomastia secondary to testosterone replacement therapy: This is the most likely diagnosis given the temporal relationship between TRT initiation and the development of gynecomastia. Testosterone can be aromatized to estrogen, which may stimulate breast tissue growth in men.
2. Idiopathic gynecomastia: This is a common cause of gynecomastia in older men and may occur without an identifiable underlying cause. However, the presence of TRT makes this less likely as the primary cause.
3. Breast cancer: Although rare in men, breast cancer should be considered, especially if the gynecomastia is unilateral, asymmetric, or associated with a palpable mass, skin changes, or nipple discharge. However, the absence of these features makes this less likely.

**Proposed plan:**

1. Further evaluation: A detailed physical examination of the breast tissue is needed to assess for asymmetry, palpable masses, skin changes, or nipple discharge. If a palpable mass is found, a breast ultrasound or mammogram may be indicated to rule out malignancy. Blood tests to assess testosterone, estrogen, and prolactin levels may also be helpful in determining the hormonal basis of gynecomastia.

2. Medication: If gynecomastia is attributed to TRT, the use of aromatase inhibitors (e.g., anastrozole) may be considered to reduce estrogen levels and alleviate symptoms. These medications are typically used in cases of gynecomastia secondary to exogenous testosterone. However, they should be used with caution, as they may have side effects such as osteoporosis or hot flashes. Alternatively, selective estrogen receptor modulators (SERMs) such as tamoxifen may be used, though they are less commonly used in this setting.

3. Non-drug management and education: The patient should be advised to maintain a healthy lifestyle, including a balanced diet and regular exercise, to manage weight and reduce the risk of metabolic complications. He should also be educated on the potential side effects of TRT and the importance of regular follow-up with his healthcare provider. If the gynecomastia is causing significant distress, referral to a plastic surgeon for possible surgical options (e.g., liposuction or mastectomy) may be considered.

4. Follow-up: The patient should be reassessed in 2 to 4 weeks to evaluate the response to any interventions and to monitor for any changes in symptoms. If the gynecomastia persists or worsens, further investigations such as imaging or hormone testing may be warranted.

